Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis
Clinical trial NCT05502731 · UNKNOWN
Trial details
- NCT number
- NCT05502731
- Sponsor
- Leiden University Medical Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2025-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.